BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancer oleh Fushun Fan, Minhua Zhou, Xiaolan Ye, Zhenxian Mo, Yaru Ma, Liying Luo, Xiaotong Liang, Haiqi Liu, Yunwo Weng, Mingsheng Lin, Xinjian Liu, Xiong Cai, Changgeng Qian